FLFabiana Gulin Longhi

Fabiana Gulin Longhi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fabiana Gulin Longhi has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Instrumentos para evaluar la calidad de los servicios en enfermedades crónicas: revisión de alcance

    by Gutembergue Santos de Sousa, Fabiane Verônica da Silva, Fabiana Gulin Longhi, Denise da Costa Boamorte Cortela, Pãmela Rodrigues De Souza Silva, Silvana Margarida Benevides Ferreira

    Mapear la literatura científica sobre la validación de instrumentos para evaluar la calidad de los servicios prestados en la atención primaria de salud para enfermedades crónicas relacionadas con la hipertensión arterial sistémica, diabetes mellitus, lepra y tuberculosis.

  • Open Access

    Instrumentos para avaliação da qualidade de serviços em doenças crônicas: revisão de escopo

    by Gutembergue Santos de Sousa, Fabiane Verônica da Silva, Fabiana Gulin Longhi, Denise da Costa Boamorte Cortela, Pãmela Rodrigues De Souza Silva, Silvana Margarida Benevides Ferreira

    Mapear a literatura científica sobre a validação de instrumentos para a avaliação da qualidade dos serviços prestados na atenção primária à saúde em doenças crônicas relacionadas com hipertensão arterial sistêmica, diabetes mellitus, hanseníase e tuberculose.

  • Open Access

    Instruments for evaluating the quality of services in chronic diseases: scoping review

    by Gutembergue Santos de Sousa, Fabiane Verônica da Silva, Fabiana Gulin Longhi, Denise da Costa Boamorte Cortela, Pãmela Rodrigues De Souza Silva, Silvana Margarida Benevides Ferreira

    To map the scientific literature on the validity of instruments for evaluating the quality of services provided in primary health care for chronic diseases related to systemic arterial hypertension, diabetes mellitus, leprosy and tuberculosis.


  • Organizational factors and safe food handling by food service workers: a scoping review protocol

    by Letícia Guimarães Perdomo Nascimento, Silvana Margarida Benevides Ferreira, Fabiana Gulin Longhi Palacio, Juliana Takahashi, Vilanice Alves de Araújo Puschel, Ageo Mario Candido da Silva, Diogo Thimoteo da Cunha

    Objective: The objective of this scoping review is to explore and map the scientific evidence on organizational factors related to safe food handling by food service workers to prevent foodborne disease. Introduction: According to the World Health Organization, more than 600 million people become ill each year due to foodborne diseases. Improper food handling is one of the main causes of such diseases. Despite the growing literature on safe food handling, many studies focus on assessing and discussing cognitive variables, such as food safety knowledge. This indicates a need to study this topic from a new perspective, for example, through its organizational factors. Inclusion criteria: The review will include quantitative and qualitative studies on food handlers working in food services. Food handlers involved in industrial processing, planting, harvesting, and working on the street (street food) or in the home will be excluded. Methods: This review will use the JBI methodology for scoping reviews to identify published and unpublished studies in all languages, with no time limit. The following databases will be searched: Scopus, CINAHL, Embase, Web of Science, MEDLINE, PsycINFO, and Food Science and Technology Abstracts. A structured search for gray literature will also be conducted. Titles, abstracts, and full texts of articles will be screened by 2 reviewers for inclusion, with discrepancies resolved by a third reviewer. Data will be extracted using a standardized form. The results will be summarized in tabular or graphical format, accompanied by a narrative summary. Key details of this review project are available in Open Science Framework: https://osf.io/hxfe4


  • Open Access

    Leprosy patients quality of life: a scoping review

    by Raissa Mariah Ferraz Moreira Barcelos, Gutembergue Santos de Sousa, Michelle Veiga de Almeida, Fabiana Gulin Longhi Palacio, Maria Aparecida Munhoz Gaíva, Silvana Margarida Benevides Ferreira

    Objective: To explore the scientific evidence regarding the leprosy patients quality of life. Method: Scoping review according to the Joanna Briggs Institute methodology, with articles indexed in PubMed, Cochrane, LILACS, Embase, CINAHL, Scopus, Web of Science, PsyINFO, INFOLEP, and Google Scholar databases, published in full in Portuguese, English, or Spanish. Results: Seventy-four studies were identified, with 71 of quantitative approach and 3 with a mixed method. There was a predominance of studies published in Brazil (58.1%), with an adult population, (97.3%) and recruited in reference centers for the treatment of leprosy (52.7%). There was greater use of the WHOQOL-bref (50%) and SF-36 (18.9%) instruments to assess quality of life. The study showed that the greatest impairment in quality of life was related to the delay in the diagnosis of the disease, to leprosy reactions, physical disabilities, neuropathic pain, and stigma. Conclusion: Most studies were developed in endemic countries, with adults, and based on observational studies, and the worst scores obtained were associated with physical domain impairment.


  • Open Access

    Incidência da Leishmaniose Tegumentar Americana no Centro-Sul de Mato Grosso, Brasil entre 2000 a 2019

    by Julianne Pachiega, Giovanna Maria Simioni Silva, Rose Margarethe Costa, Fabiana Gulin Longhi, Andernice dos Santos Zanetti Espinosa, Omar Ariel Espinosa Domínguez

    A Leishmaniose Tegumentar Americana (LTA) é uma doença zoonótica negligenciada, que afeta a pele e as mucosas, causada por diferentes espécies do gênero Leishmania. O objetivo deste estudo foi analisar o perfil demográfico, clínico, geográfico e temporal dos casos de LTA registrados no período 2000-2019, na secretaria de saúde do município de Cáceres/MT. A informação demográfica dos casos registrados foi analisada por: Perfil demográfico, Aspectos clínicos, Distribuição geográfica e temporal e Taxa de incidência anual. A maior prevalência encontrada foi em homens na faixa etária de 20 a 60 anos. Aproximadamente 81% dos casos eram de leishmaniose cutânea. As profissões mais afetadas foram os lavradores e trabalhadores braçais. A proporção entre os casos rurais e urbanos foi similar. Ao analisar o perfil demográfico apenas dos casos urbanos, os aposentados, donas do lar e estudantes foram o grupo mais afetado. A LTA foi amplamente distribuída, em diversos bairros do centro urbano da cidade. Concluímos que a LTA em Cáceres/MT afeta principalmente a população produtiva masculina. Contudo, nos casos urbanos a população mais afetada esta formada por aposentados, donas do lar e estudantes sugerindo a possibilidade de eventuais surtos endêmicos.


  • Open Access

    Prevalence of Blastocystis sp. infection in several hosts in Brazil: a systematic review and meta-analysis

    by Andernice dos Santos Zanetti, Antonio Francisco Malheiros, Tatiane Amorim de Matos, Fabiana Gulin Longhi, Luciana Melhorança Moreira, Samuel Laudelino Silva, Solange Kimie Ikeda Castrillon, Silvana Margarida Benevides Ferreira, Eliane Ignotti, Omar Ariel Espinosa

    Background: Blastocystis sp. affects a wide variety of animals and is the most common protozoan in human fecal samples with potential pandemic distribution. In the present study, a systematic review and meta-analysis were conducted to determine the prevalence and distribution of Blastocystis sp. in different classes of hosts in Brazil. Methods: Studies that analyzed hosts of various classes, including humans, domestic animals, wild animals or captive animals, were considered. The pooled prevalence of Blastocystis sp. infection was estimated by random effects models. Results: For humans, similar prevalence rates were found for males (31.0%, 95% CI: 17.0–45.0%; weight 10%) and females (28.0%, 95% CI: 16.0–41.0%; weight 10%); the state of Mato Grosso do Sul showed the highest prevalence, with 41.0% positivity (95% CI: 36.0–46.0%; weight 2.9%). The prevalence among immunocompromised patients was 5.0% (95% CI: 3.0–7.0%; weight 10%), and the most common cause of immunosuppression was hemodialysis, with 23.0% (95% CI: 17.0–29.0%; weight 12.4%). Among classifications according to interaction with humans, wild and domestic animals presented values of 19.0% (95% CI: 7.0–31.0%; weight 42.6%) and 17.0% (95% CI: 13.0–21.0%; weight 29.6%), respectively. Among these animals, mammals (39.0%, 95% CI: 21.0–56.0%; weight 47.3%) and birds (18.0%, 95% CI: 10.0–27.0%; weight 39.3%) exhibited the highest prevalence. Phylogenetic analysis of Blastocystis sp. revealed greater genetic diversity for clades of subtypes (STs) ST1, ST2 and ST3. Conclusions: The overall prevalence of Blastocystis sp. in the Brazilian human population was 24%, which reflects the reality in the South, Southeast and Midwest regions, where prevalence rates of up to 40% were found. Among animals, mammals and birds exhibited the highest prevalence.


  • Open Access

    Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil

    by Julianne Pachiega, Alexandre José dos Santos Afonso, Géssica Thaís Sinhorin, Bianca Teshima de Alencar, Marta dos Santos Miranda de Araújo, Fabiana Gulin Longhi, Andernice dos Santos Zanetti, Omar Ariel Espinosa

    Age, sex and presence of comorbidities are risk factors associated with COVID-19. Hypertension, diabetes and heart disease are the most common comorbidities in patients with COVID-19. The objective of this study was to estimate the prevalence of patients with comorbidities who died of COVID-19 in Brazil. Searches of data were carried out on the official pages of the 26 State health departments and the federal district. The random-effect method was used to calculate the prevalence of patients with comorbidities who died. From the beginning of the pandemic in Brazil until May 20, 2020, 276,703 cases of COVID-19 were notified in Brazil, 6.4% died, 58.6% of whom were male. The prevalence of comorbidities among deaths was 83% (95% CI: 79 - 87), with heart disease and diabetes being the most prevalent. To our knowledge, this study represents the first large analysis of cases of patients with confirmed COVID-19 in Brazil. There is a high prevalence of comorbidities (83%) among patients who died from COVID-19 in Brazil, with heart disease being the most prevalent. This is important considering the possible secondary effects produced by drugs such as hydroxychloroquine.


  • Open Access

    Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis

    by Omar Ariel Espinosa, Andernice dos Santos Zanetti, Ednardo Fornanciari Antunes, Fabiana Gulin Longhi, Tatiane Amorim de Matos, Paula Franciene Battaglini

    The new coronavirus, COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. Risk factors associated with this disease are age, sex, and the presence of comorbidities, the most common being hypertension, diabetes, and heart disease. The aim of this meta-analysis was to calculate the prevalence and geographical distribution of comorbidities in all patients admitted to intensive care units (ICUs), and the mortality rate of COVID-19. We selected studies based upon epidemiological and clinical descriptions of the patients and mortality from the disease to determine the pooled prevalence of comorbidities in all patients and in mortality cases due to COVID-19. The pooled prevalence was estimated using the random effects model, and odds ratios were used to measure the probability of death for a patient with a comorbidity. The total prevalence of comorbidities in patients with COVID-19 was 42% (95% CI: 25-60), 61% (95% CI: 42-80) in those admitted to the ICU, and 77% (95% CI: 68-86) among death cases; males were the most affected. Hypertension was the most prevalent comorbidity in all three groups studied, accounting for 32%, 26%, and 35%, respectively. The odds ratio of death for a patient with a comorbidity compared to one with no comorbidity was 2.4 (P < 0.0001). The higher the prevalence of comorbidities the higher the odds that the COVID-19 patient will need intensive care or will die, especially if the pre-existing disease is hypertension, heart disease, or diabetes.


  • Open Access

    Diagnostic accuracy of Enzyme-Linked Immunosorbent Assays to detect anti-Leishmania antibodies in patients with American Tegumentary Leishmaniasis: a systematic review

    by Andernice dos Santos Zanetti, Camila Massae Sato, Fabiana Gulin Longhi, Silvana Margarida Benevides Ferreira, Omar Ariel Espinosa

    American Tegumentary leishmaniasis (ATL) is an infectious disease caused by several species of Leishmania . Even though the direct detection of parasites has low sensitivity, it is still the gold standard for the laboratory diagnosis of ATL. Recent studies have shown promising results of Enzyme-Linked Immunosorbent Assays ( ELISAs) using recombinant antigens. The aim of this study is to compare the accuracy of ELISAs using novel antigens with the standard ELISA based on soluble antigens of Leishmania (SLA) to diagnose ATL. Studies that analyzed patients with ATL and studies that evaluated the diagnostic accuracy of ELISAs using novel antigens and SLA were included. The Fourteen studies from PubMed, Regional Portal of the Virtual Health Library (BVS), Brazilian Society of Dermatology, Virtual Health Library (IBECS), Literature in the Health Sciences in Latin America and the Caribbean (LILACS), Medical Literature Analysis and Retrieval System Online (Medline), Elsevier Embase, Cochrane Library, The National Institute for Health and Care Excellence (NICE), and Cumulative Index to Nursing and Allied Health Literature (CINAHL) were included. The novel ELISA antigens showed a high sensitivity (93.8%-100%) and specificity (82.5-100%), a better diagnostic performance than SLA-based ELISAs (1-97.4% and 57.5-100%, respectively). Only 10 studies analyzed cross-reactions in serum samples from patients with Chagas disease, and only two studies reported a percentage of cross-reactivity. In this systematic review, the novel ELISA antigens showed better sensitivity and specificity with respect to SLA-based ELISAs. However, a meta-analysis should be performed to confirm this finding.